论文部分内容阅读
目的了解我院乳腺癌患者病理及治疗情况,了解与我国诊疗规范间存在的差距。方法分析2008年1月1日~2013年12月31日我院收治的乳腺癌患者的资料,按照《中国抗癌协会乳腺癌诊治指南与规范》2013版设计调查表,通过查阅病例和电话随访,将资料分类汇总后与规范比较。结果 331例乳腺癌患者入组,中位确诊年龄51岁,浸润性导管癌85.20%,Ⅰ期14.5%、Ⅱ期49.5%、Ⅲ期30.8%、Ⅳ期1.2%。改良根治术是主要术式,保乳率及前哨淋巴结活检率分别为5.7%、7.3%。根据规范,应该接受化疗、放疗和内分泌治疗的患者中实际接受治疗的患者分别为91.5%、64.9%、69.9%。结论我院乳腺癌患者的病理分期偏晚,治疗与我国乳腺癌指南存在一定差距,需进一步提高。
Objective To understand the pathology and treatment of patients with breast cancer in our hospital and to find out the gap between them and the medical treatment norms in our country. Methods The data of patients with breast cancer treated in our hospital from January 1, 2008 to December 31, 2013 were analyzed. According to the design questionnaire of 2013 version of Guideline and Practice of Breast Cancer Diagnosis and Treatment of China Anti-Cancer Association, , The data are summarized and compared with the standard classification. Results Among 331 breast cancer patients, the median age at diagnosis was 51 years, invasive ductal carcinoma 85.20%, stage I 14.5%, stage II 49.5%, stage III 30.8% and stage IV 1.2%. Modified radical mastectomy is the main procedure, breast-conserving rate and sentinel lymph node biopsy rates were 5.7%, 7.3%. According to the norm, the actual patients receiving chemotherapy, radiotherapy and endocrine therapy were 91.5%, 64.9% and 69.9% respectively. Conclusion The pathological stage of breast cancer patients in our hospital is late, and there is a certain gap between the treatment and the guidelines for breast cancer in our hospital, which need to be further improved.